You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 46 No. 11, November 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antineural Autoantibodies in Patients With Paraneoplastic Cerebellar Degeneration

Tetsuro Tsukamoto, MD; Hirotaka Yamamoto, PhD; Yuzo Iwasaki, MD; Osamu Yoshie, MD; Hiroshi Terunuma, MD; Hiroyoshi Suzuki, MD

Arch Neurol. 1989;46(11):1225-1229.


Abstract

• We studied serum autoantibodies from six patients with paraneoplastic cerebellar degeneration using rat brains. Immunohistochemically, serum samples from four of six patients with uterine or ovarian tumors showed a similar staining pattern, labeling Purkinje cells and various other neurons distributed throughout the brain and spinal cord. The immunoblot study showed that these serum samples recognized the common 52-kd band. Serum from a patient with duct carcinoma of the breast reacted with the 46-kd band with a similar but weaker immunohistochemical reactivity. Serum from another patient with small-cell carcinoma of the lung in whom paraneoplastic cerebellar degeneration and Eaton-Lambert myasthenic syndrome developed recognized the 40-kd and 38-kd bands with a different immunostaining pattern. Autoantibodies in patients with paraneoplastic cerebellar degeneration are directed to a variety of neuronal antigens that may differ from patient to patient.



Author Affiliations

From the Department of Neurology (Dr Tsukamoto), Fukushima (Japan) Medical College; and the Departments of Neurological Sciences (Drs Yamamoto, Iwasaki, Terunuma, and Suzuki) and Bacteriology (Dr Yoshie), Tohoku University School of Medicine, Sendai, Japan.


Footnotes

Accepted for publication March 13, 1989.

Reprint requests to Department of Neurology, Fukushima Medical College, Hikari-ga-oka 1, Fukushima 960-12, Japan (Dr Tsukamoto).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Post-Transcriptional Regulatory Mechanism Restricts Expression of the Paraneoplastic Cerebellar Degeneration Antigen cdr2 to Immune Privileged Tissues
Corradi et al.
J. Neurosci. 1997;17:1406-1415.
ABSTRACT | FULL TEXT  

Ultrastructural Localization of Anti-Purkinje Cell Antibody--Binding Sites in Paraneoplastic Cerebellar Degeneration
Hida et al.
Arch Neurol 1994;51:555-558.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.